Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IPHA Innate Pharma > Detailed Quotes

IPHA Innate Pharma

Watchlist
2.190
-0.100-4.37%
Close 12/02 16:00 ET
High
2.360
Open
2.280
Turnover
34.80K
Low
2.170
Pre Close
2.290
Volume
15.32K
Market Cap
174.97M
P/E(TTM)
Loss
52wk High
5.380
Shares
79.89M
P/E(Static)
Loss
52wk Low
1.920
Float Cap
113.87M
Bid/Ask %
33.33%
Historical High
11.950
Shs Float
52.00M
Volume Ratio
8.07
Historical Low
1.920
Dividend TTM
--
Div Yield TTM
--
P/B
1.43
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.03%
Amplitude
8.30%
Avg Price
2.271
Lot Size
1
Float Cap
113.87M
Bid/Ask %
33.33%
Historical High
11.950
Shs Float
52.00M
Volume Ratio
8.07
Historical Low
1.920
Dividend TTM
--
P/B
1.43
Dividend LFY
--
Turnover Ratio
0.03%
Amplitude
8.30%
Avg Price
2.271
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
CEO: Dr. Mondher Mahjoubi, M.D.
Market: NASDAQ
Listing Date: 10/17/2019
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist